TAM shares with Stormoken syndrome (STRMK) gain-of-function mutations of STIM1 and ORAI1 (104–106), leading to excess intracellular calcium influx, possibly favored by a reduced DES action on the SOCE pathway. The gene discussed is STIM1; the disease is transient myeloproliferative syndrome.